March 2012

TABLE OF CONTENTS

A Spate of Spin-Offs
Derek G. Hennecke begins part 1 of his 6-part series on lessons learned from other industries.

Technology Trendsin the Pharmaceutical & Biopharmaceutical Industry
Frost & Sullivan Analyst Cecilia E. Van Cauwenberghe believes that although the main competitive behavior around the pharmaceutical industry is based on technology differentiation and cost-based strategies, the rules governing the course of the industry are based on a complex understanding of the principal actors’ interaction.

In Vitro Diffusion Studies in Transdermal Research: A Synthetic Membrane Model in Place of Human Skin
Vivek Joshi, PhD, David Brewster, and Peter Colonero present data on the applicability of a synthetic membrane (Strat-MTM) for in vitro transdermal diffusion studies in place of human or animal skin as a model.

Analytical Instruments: Global Demands, Innovations & Cost-Savings
Contributor Cindy H. Dubin recently spoke with some of the leading companies that offer analytical instrument equipment and services to find out how they are addressing pharma’s needs for faster (and more cost-efficient) testing.

COVER

FEATURES